Its withdrawal from various markets reflected commercial decisions, not emergent safety signals
Tirzepatide is FDA-approved as a branded prescription medication
Significant weight loss may leave patients with stretched, sagging skin, especially in the abdomen Significant weight loss, which is attainable with these effective prescriptions, may lead to loose or sagging skin as the skin loses elasticity and doesnt shrink back completely
Global GLP-1 Receptor Agonist Market Size: Forecast (2026-2032) The Global GLP-1 Receptor Agonist Market size was valued at around USD 52.39 billion in 2025 and is projected to grow from USD 63.2 billion in 2026 to USD 78.4 billion by 2032
They couldnt be more wrong
However, glutathione levels naturally decline with age, stress, illness, and exposure to environmental toxins, creating a potential gap in cellular protection